The Mexico Federal Commission for the Protection Against Sanitary Risk (Cofepris) on Wednesday has granted authorization for the emergency use of India's first domestically-produced COVID-19 vaccine, Covaxin.
"The decision by Cofepris to authorize the emergency use of the Covaxin vaccine produced in India was made very timely. Mexico's COVID-19 vaccination opportunities are expanding," Mexican Foreign Minister Marcelo Ebrard said in a tweet.
Since the beginning of the vaccination campaign, the Mexican authorities have distributed over 9.6 million doses of vaccines, mainly among the elderly and doctors. The massive campaign began in the second half of February, reported Sputnik.
Currently, there are five different vaccines that are being used in Mexico, either purchased from abroad or produced locally--Pfizer/BioNTech, Oxford/AstraZeneca, Sinovac, Cansino, and Sputnik V.
According to Johns Hopkins University, Mexico has a total of 2,256,509 COVID-19 cases. As many as 204,985 people have died so far in the country.
Starbucks In US' New Mexico Nicknamed "Charbucks" After 2 Arson Attacks People In This Mexican State Drink Coca-Cola More Than Water, As Per Reports Ancient Pyramids Collapse In Mexico, Local Tribe Warns Of "Impending Doom" US Millionaire, Who Died By Suicide, Owed $34 Million With $8,000 In Bank Elderly Man Slapped, Abused On Train Over Suspicion Of Carrying Beef UK's Seat Should Go To India: Ex-Diplomat On UN Security Council Reforms 8 Killed After Bus Carrying 47 Overturns In US State Of Mississippi: Report Trump "Disrespected Sacred Ground' At US Military Cemetery: Kamala Harris Top 10 US Universities Based On Forbes Rankings 2024 Track Latest News Live on NDTV.com and get news updates from India and around the world.